ampelopsin has been researched along with bay 11-7082 in 1 studies
| Studies (ampelopsin) | Trials (ampelopsin) | Recent Studies (post-2010) (ampelopsin) | Studies (bay 11-7082) | Trials (bay 11-7082) | Recent Studies (post-2010) (bay 11-7082) |
|---|---|---|---|---|---|
| 377 | 2 | 343 | 570 | 1 | 383 |
| Protein | Taxonomy | ampelopsin (IC50) | bay 11-7082 (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.82 | |
| Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) | 2 | |
| Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) | 2 | |
| Transcription factor p65 | Homo sapiens (human) | 2.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Ding, F; Li, B; Li, S; Liu, P; Liu, T; Sun, X; Wang, F; Wang, S; Yu, N; Zhang, X; Zhao, Y | 1 |
1 other study(ies) available for ampelopsin and bay 11-7082
| Article | Year |
|---|---|
Ampelopsin reduces the migration and invasion of ovarian cancer cells via inhibition of epithelial-to-mesenchymal transition.
Topics: Active Transport, Cell Nucleus; Antineoplastic Agents; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Flavonoids; Humans; I-kappa B Proteins; Neoplasm Metastasis; NF-kappa B; NF-KappaB Inhibitor alpha; Nitriles; Ovarian Neoplasms; Sulfones; Time Factors; Up-Regulation; Vimentin | 2015 |